Diphtheria

Diphtheria is a bacterial caused by toxigenic strains of Corynebacterium diphtheria (C. diphtheria), and most often causes infection of the upper and leads to the clinical syndromes including , naso-pharyngitis, , (or any combination of these) and a firmly adherent pseudo membrane over the , , and/or nares. In severe cases, infection can spread into causing tracheiitis and/or severe cervical adenopathy leading to life-threatening .

Probable Case A person with an illness characterized by laryngitis or pharyngitis or tonsillitis, and an adherent membrane of the tonsils, pharynx and/or nose OR gross

Five things to do with a probable case*

1. Isolate patient immediately and apply standard droplet and contact precautions when caring for the patient. 2. Administer diphtheria antitoxin (DAT) as soon as possible if in field hospital. 3. Administer ( or ) following DAT as soon as possible. 4. Monitor closely and provide supportive therapy for severe complications (i.e. airway management, cardiac, neurologic and renal failure). 5. Vaccinate *See flow chart on back of page

Infection Prevention and Control

1. Place patients with suspected or confirmed diphtheria in isolation room (area). 2. Apply standard precautions, including hand hygiene at all times. 3. In addition, also apply droplet and contact precautions. 4. The disease is usually not contagious 48 hours after treatment. 5. After discharge, restrict contact with others until completion of therapy.

For all identified close contacts:

1. Identify all close contacts 2. Administer prophylaxis for close contacts IM benzathine penicillin: a single dose For children aged ≤ 5 years: administer 600 000 units For those > 5 years: administer 1 200 000 units OR Oral Children: 10-12 mg/kg once daily, to a max of 500mg/day. Treat for total 7 days Adults: 500mg once daily. Treat for total 7 days. OR Oral erythromycin For children: 40 mg/kg/day, administered in divided dose, 10 mg per dose, every 6 hours For adults: 1 g/day for adults, administered in divided dose, 250 mg per dose every 6 hours Treat for total 7 days 3. All identified contacts should be closely monitored for seven days and seek treatment if symptomatic

TRIAGE

Some patients may present weeks after URTI Sore symptoms with new onset URTI symptoms Refer to Infection of cardiac renal or +/- +/- neurological symptoms Prevention and Control measures Clinician wearing protection

examines throat Early Pseudo- membrane URTI Pseudo-membrane seen OR gross No Advice to return if no lymphadenopathy improvement. Give Yes

Are there Clinical Warning Signs? Bull Pseudo-Membrane Fast Respiratory Rate Chest in-drawing Restlessness or lethargy Bull neck Delayed capillary refill

Fast Heart rate and cold extremities Central Cyanosis

Yes No

DAT (give as soon as possible) Antibiotics (give as soon as possible) Antibiotics (give as soon as possible)

Contact Tracing, Vaccination, and Prophylaxis for Contacts and for Prophylaxis Tracing, Contact Vaccination,

Field Hospital Isolation facility for at least 48 hours

DAT dose Oral penicillin V Contac 20,000-100,000 IU 10-15 mg/kg/dose administered every 6 hours. t Maximum is 500 mg per dose. Treat for 14 days. Aqueous benzyl penicillin (penicillin G): (IM or IV) 25 000 units/kg everyTracing 6 hours* . Treat for 14 days. Oral erythromycin 10 mg/kg administered every 6 hours. Maximum is When patients are able to swallow, switch to oral 500 mg per dose. Treat for 14 days. antibiotics to complete course (14 days) Oral azithromycin 10 mg/kg administered once daily. Laboratory sampling on a case by case basis Maximum is 500 mg per day. Treat for 14 days. *Maximum dose is 4 MIU Monitor for deterioration, refer to field hospital if patient worsens